share_log

Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know

Benzinga ·  Apr 17 15:00

4 analysts have shared their evaluations of Travere Therapeutics (NASDAQ:TVTX) during the recent three months, expressing a mix of bullish and bearish perspectives.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings12100
Last 30D01000
1M Ago00000
2M Ago10000
3M Ago01100

Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $13.0, a high estimate of $17.00, and a low estimate of $9.00. This current average reflects an increase of 4.0% from the previous average price target of $12.50.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

The analysis of recent analyst actions sheds light...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment